Nexus Surgical & Med
Ticker > Company >

Nexus Surgical & Med share price

Nexus Surgical And Medicare Ltd.

BSE: 538874 SECTOR: Trading  23.17 K   32   0

18.10
-0.02 (-0.11%)
BSE: 03 Nov 04:01 PM

Price Summary

Today's High

₹ 18.1

Today's Low

₹ 18.1

52 Week High

₹ 29.28

52 Week Low

₹ 13.8

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 9.9 Cr.

Enterprise Value

₹ 9.57 Cr.

No. of Shares

0.55 Cr.

P/E

17.66

P/B

8.14

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  2.22

CASH

₹ 0.33 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

18.73 %

EPS (TTM)

₹  1.03

Sales Growth

64.67%

ROE

61.03 %

ROCE

83.16%

Profit Growth

133.18 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year64.67%
3 Year33.68%
5 Year27%

Profit Growth

1 Year133.18%
3 Year19.67%
5 Year15.93%

ROE%

1 Year61.03%
3 Year57.08%
5 Year190.53%

ROCE %

1 Year83.16%
3 Year77.88%
5 Year256.34%

Debt/Equity

0

Price to Cash Flow

95

Interest Cover Ratio

68.7913

CFO/PAT (5 Yr. Avg.)

0.247398321011705

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 18.73 0.00
Jun 2025 18.73 0.00
Mar 2025 18.73 0.00
Dec 2024 18.73 0.00
Sep 2024 18.73 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 33.6758349352309% for the Past 3 years.
  • Company has been maintaining healthy ROE of 57.0795% over the past 3 years.
  • Company has been maintaining healthy ROCE of 77.8838666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.132555087892287.
  • The company has an efficient Cash Conversion Cycle of -142.3455 days.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 1.76 1 1.48 1.48 1.73
Total Expenditure 1.64 0.72 1.33 1.37 1.52
Operating Profit 0.12 0.28 0.15 0.12 0.21
Other Income 0 0 0 0.01 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.12 0.28 0.15 0.12 0.2
Tax 0.03 0.07 0.04 0.03 0.05
Profit After Tax 0.09 0.21 0.11 0.09 0.15
Adjusted EPS (Rs) 0.16 0.38 0.21 0.16 0.28

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 3.74 2.4 1.55 3.47 5.72
Total Expenditure 3.58 2.03 1.34 3.2 5.05
Operating Profit 0.16 0.37 0.22 0.27 0.67
Other Income 0.01 0.02 0.01 0.03 0.01
Interest 0 0 0 0.01 0.01
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.17 0.39 0.23 0.29 0.67
Tax 0.02 0.1 0.06 0.08 0.17
Net Profit 0.15 0.29 0.17 0.21 0.5
Adjusted EPS (Rs.) 0.28 0.53 0.31 0.39 0.91

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.47 5.47 5.47 5.47 5.47
Total Reserves -5.58 -5.29 -5.12 -4.91 -4.41
Borrowings 0 0 0 0 0
Other N/C liabilities -0.01 -0.01 -0.01 -0.01 -0.01
Current liabilities 1.04 1.82 0.56 1.24 1.21
Total Liabilities 0.92 1.99 0.91 1.8 2.27
Assets
Net Block 0.02 0.01 0.02 0.02 0.02
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.09 0.18 0 0.03 0
Other N/C Assets 0 0 0 0 0
Current Assets 0.81 1.8 0.88 1.75 2.24
Total Assets 0.92 1.99 0.91 1.8 2.27
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.17 0.39 0.23 0.29 0.67
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities 0.03 -0.5 0.32 -0.71 -0.57
Tax Paid 0 0 0 0 0
Operating Cash Flow 0.2 -0.11 0.55 -0.41 0.1
Investing Cash Flow 0 0 -0.01 0 -0.01
Financing Cash Flow 0 0 0 0 0
Net Cash Flow 0.2 -0.11 0.54 -0.42 0.1

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 18.73 18.73 18.73 18.73 18.73
mildred mercantile privat... 18.55 18.55 18.55 18.55 18.55
ramasubramanian p 0.09 0.09 0.09 0.09 0.09
venkatramani n 0.09 0.09 0.09 0.09 0.09
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 81.27 81.27 81.27 81.27 81.27
a & a capital services pv... 2.64 2.64 2.64 2.64 2.64
acquitor financial servic... 1.49 - 2.16 2.22 2.72
alpana sharma 1.83 1.83 1.83 1.83 1.83
ashok kumar dugar 1.46 1.46 1.46 1.46 1.46
bhanabhai g parmar 3.51 3.51 3.51 3.51 3.51
desh raj singha 1.83 1.83 1.83 1.83 1.83
globe capital market limi... 2.38 2.38 2.38 2.38 2.38
harivardhan steel & alloy... 14.78 16.01 16.01 16.07 16.07
kawaljeet singh duggal 1.83 1.83 1.83 1.83 1.83
khattu constructions and ... 4.79 4.79 4.79 4.79 4.79
nishu finlease private li... 1.10 1.10 1.10 1.10 1.10
rajendrabhai bhanushankar... 1.83 1.83 1.83 1.83 1.83
rishabh negi - - - - 1.00
ritika chona 1.83 1.83 1.83 1.83 1.83
ruchee chotra 1.46 1.46 1.46 1.46 1.46
shyam alcohol and chemica... 6.27 6.27 5.00 5.00 5.00
yadvendra sharma 2.49 2.49 2.49 2.49 2.49
laxman sopan waghmode - - 1.02 1.02 -
rajeev kumar singh 1.83 1.83 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Nexus Surgical & Med Stock Price Analysis and Quick Research Report. Is Nexus Surgical & Med an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Nexus Surgical & Med. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nexus Surgical & Med has a PE ratio of 17.6550916894265 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nexus Surgical & Med has ROA of 24.4678% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nexus Surgical & Med has a Current ratio of 1.8527.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nexus Surgical & Med has a ROE of 61.0329%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Nexus Surgical & Med has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Nexus Surgical & Med has reported revenue growth of 64.668% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Nexus Surgical & Med for the current financial year is 11.787544239607%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nexus Surgical & Med is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Nexus Surgical & Med is Rs 1.0252. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Nexus Surgical & Med in Ticker for free. Also, one can get the intrinsic value of Nexus Surgical & Med by using Valuation Calculators, which are available with a Finology ONE subscription. 

Nexus Surgical & Med FAQs

Q1. What is Nexus Surgical & Med share price today?
Ans: The current share price of Nexus Surgical & Med is Rs 18.1.

Q2. What is the market capitalisation of Nexus Surgical & Med?
Ans: Nexus Surgical & Med has a market capitalisation of Rs 9.904139 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Nexus Surgical & Med?
Ans: The PE ratio of Nexus Surgical & Med is 17.6550916894265 and the P/B ratio of Nexus Surgical & Med is 8.14068543671854, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Nexus Surgical & Med share?
Ans: The 52-week high share price of Nexus Surgical & Med is Rs 29.28, and the 52-week low share price of Nexus Surgical & Med is Rs 13.8.

Q5. Does Nexus Surgical & Med pay dividends?
Ans: Currently, Nexus Surgical & Med does not pay dividends. Dividend yield of Nexus Surgical & Med is around 0%.

Q6. What are the face value and book value of Nexus Surgical & Med shares?
Ans: The face value of Nexus Surgical & Med shares is Rs 10, while the book value per share of Nexus Surgical & Med is around Rs 2.2234. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Nexus Surgical & Med?
Ans: Nexus Surgical & Med has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Nexus Surgical & Med?
Ans: The ROE of Nexus Surgical & Med is 61.0329% and ROCE of Nexus Surgical & Med is 83.1649%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Nexus Surgical & Med a good buy for the long term?
Ans: The Nexus Surgical & Med long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Nexus Surgical & Med undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Nexus Surgical & Med appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Nexus Surgical & Med’s financials?
Ans: You can review Nexus Surgical & Med’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Nexus Surgical & Med
X